JUNS · Company research
Jupiter Neurosciences, Inc. Common Stock (JUNS): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A Tiny Psychedelic Stock Just Exploded Over 50% – Retail Traders Think $1 Is Next - Stocktwits | A Tiny Psychedelic Stock Just Exploded Over 50% – Retail Traders Think $1 Is Next Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| A Parkinson’s trial has dosed its first patient. Its maker may sell or license its clinical programs. - Stock Titan | A Parkinson’s trial has dosed its first patient. Its maker may sell or license its clinical programs. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| Jupiter Neurosciences Prices $2.0 Million Registered Direct Offering at $6.50 Per Share - TradingView | Jupiter Neurosciences Prices $2.0 Million Registered Direct Offering at $6.50 Per Share TradingView | View source ↗ | TradingView | Aug 24, 2026 | neutral | 0 | 0.6 |
| JUNS Stock Whipsaws As New Insider Files Form 3 - StocksToTrade | JUNS Stock Whipsaws As New Insider Files Form 3 StocksToTrade | View source ↗ | StocksToTrade | Aug 21, 2026 | neutral | 0 | 0.6 |
| JUNS Stock Jumps As New Insider Stake Hits The Tape - Timothy Sykes | JUNS Stock Jumps As New Insider Stake Hits The Tape Timothy Sykes | View source ↗ | Timothy Sykes | Aug 21, 2026 | neutral | 0 | 0.6 |
| Jupiter Neurosciences proposes selling 307,692 shares for about $2 million - Stock Titan | Jupiter Neurosciences proposes selling 307,692 shares for about $2 million Stock Titan | View source ↗ | Stock Titan | Aug 21, 2026 | neutral | 0 | 0.6 |
| JUNS Stock Jumps As New Insider Ownership Revealed - StocksToTrade | JUNS Stock Jumps As New Insider Ownership Revealed StocksToTrade | View source ↗ | StocksToTrade | Aug 21, 2026 | neutral | 0 | 0.6 |
| Jupiter Neurosciences Surges as Post-Split Float Shrinks and Traders Revisit Pipeline Expansion - Quiver Quantitative | Jupiter Neurosciences Surges as Post-Split Float Shrinks and Traders Revisit Pipeline Expansion Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 21, 2026 | neutral | 0 | 0.6 |
| JUNS Stock Whipsaws As New Insider Ownership Is Disclosed - Timothy Sykes | JUNS Stock Whipsaws As New Insider Ownership Is Disclosed Timothy Sykes | View source ↗ | Timothy Sykes | Aug 21, 2026 | neutral | 0 | 0.6 |
| JUNS Stock Draws Focus After New Insider Ownership Filing - StocksToTrade | JUNS Stock Draws Focus After New Insider Ownership Filing StocksToTrade | View source ↗ | StocksToTrade | Aug 21, 2026 | neutral | 0 | 0.6 |
| Jupiter Neurosciences, Inc. Announces 1-for-75 Reverse Stock Split Effective August 6, 2026 | JUNS Stock News - Quiver Quantitative | Jupiter Neurosciences, Inc. Announces 1-for-75 Reverse Stock Split Effective August 6, 2026 | JUNS Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 5, 2026 | neutral | 0 | 0.6 |
| Jupiter Neurosciences, Inc. Announces Reverse Stock Split - GlobeNewswire | Jupiter Neurosciences, Inc. Announces Reverse Stock Split GlobeNewswire | View source ↗ | GlobeNewswire | Aug 5, 2026 | neutral | 0 | 0.6 |
| Jupiter Neurosciences Signs ALA-002 License Agreement Worth Up to $100 Million (NASDAQ:JUNS) - Yahoo Finance | Jupiter Neurosciences Signs ALA-002 License Agreement Worth Up to $100 Million (NASDAQ:JUNS) Yahoo Finance | View source ↗ | Yahoo Finance | Jul 21, 2026 | neutral | 0 | 0.6 |
| Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million - GlobeNewswire | Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million GlobeNewswire | View source ↗ | GlobeNewswire | Jul 21, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.